Brief: Silence Therapeutics Receives $10 Million Milestone Payment From AstraZeneca Collaboration
Feb 23 (Reuters) - Silence Therapeutics PLC SLNCF.PK :
* SILENCE THERAPEUTICS ACHIEVES $10 MILLION MILESTONE
PAYMENT FROM
ASTRAZENECA COLLABORATION FOLLOWING THE INITIATION OF PHASE 1
TRIAL
Source text for Eikon: ID:nBw860X0Ta
Further company coverage: SLNCF.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silence Therapeutics
See all newsBrief: Silence Therapeutics Reports Second Quarter 2025 Financial Results And Recent Business Highlights
Brief: Silence Therapeutics files for stock shelf, size not disclosed
Brief: Silence Therapeutics Announces Positive Results From Ongoing Sanreco Phase 1 Study
Brief: Silence Therapeutics Announces Positive Topline 48-Week Data From Phase 2 Study Of Zerlasiran In Patients With Elevated Lipoprotein
Brief: Silence Therapeutics PLC Files For Resale Of Up To 5.71 Million Shares By The Selling Securityholders - SEC Filing